Ruka hadi maudhui makuu

Condition · 4 treatment paths

Multiple Myeloma

Multiple myeloma is a cancer of plasma cells in the bone marrow that can damage bones, kidneys and blood counts. It mainly affects people over 60 and is treatable but not usually curable.

Severe

Send your imaging + plan. Board-reviewed opinion in 5–10 working days.

Ilisasishwa mwisho: Jinsi tunavyokusanya na kukagua taarifa

Linear accelerator used for radiotherapy in a cancer treatment room
Treatment paths
4Treatment paths
Specialties
1Specialties
Typical severity
SevereTypical severity

About multiple myeloma

What to know

Common features are bone pain, fatigue, anaemia, infections, high calcium and kidney problems. Diagnosis combines blood and urine tests for abnormal proteins, a bone marrow biopsy and imaging of the skeleton. Many people respond well to treatment, but the disease generally returns after periods of remission, so treatment is given in stages.

Treatment combines drug regimens, typically a proteasome inhibitor, an immunomodulatory drug, a steroid and an antibody. Fitter patients usually have high-dose chemotherapy followed by an autologous stem cell transplant. Bone-strengthening medicines and radiotherapy relieve bone damage. For relapse, CAR-T cell therapy and bispecific antibodies are options at specialist centres, and patients often travel abroad to access them.

Pre-flight workup

Tests to have already done

  • Blood and urine tests for the monoclonal protein (serum protein electrophoresis, free light chains), plus calcium, creatinine and blood counts.
  • Bone marrow biopsy report with plasma cell percentage and cytogenetics or FISH results.
  • Whole-body low-dose CT, PET-CT or MRI showing bone lesions.
  • Staging results such as beta-2 microglobulin and albumin.
  • Records of every treatment given so far, with dates, responses and side effects.

Second opinion

When to get a second look

  • You have been told you have smouldering myeloma and treatment or watching is being debated.
  • The bone marrow genetics show high-risk features and you want to confirm your treatment plan.
  • You are considering a stem cell transplant or CAR-T therapy and want to know if you qualify.
  • Your disease has returned and you want to know about newer drug combinations or trials.

Talking to your doctor

Questions to ask

  1. What stage and risk group am I, and what do my genetic results mean?
  2. Which combination of drugs do you recommend as first treatment?
  3. Am I suitable for an autologous stem cell transplant, and when?
  4. How will my bones and kidneys be protected?
  5. What is the plan if the first treatment stops working?
  6. How often will my response be measured, and what long-term maintenance is needed?

Outlook

Realistic prognosis

Myeloma is treatable but usually not curable, and it tends to relapse. Modern drug combinations, with or without stem cell transplant, often give years of remission, and many patients live many years. Outlook depends on age, fitness, cytogenetic risk, stage, kidney function and depth of response. Treatment is often given in successive lines, and supportive care for bones and infections matters.

Diagnostic workup

Before you pick a hospital, get the workup right

Severe — workup typically within 48–72 hours

Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.

  1. Confirm the diagnosis on imaging or labs

    For multiple myeloma, plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.

  2. See a oncology specialist locally first

    An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.

  3. Send us the file for a free second opinion

    Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.

  4. Pick a path with timeline + cost in writing

    Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.

04 · FAQ

Common questions about multiple myeloma

Is multiple myeloma curable?

It is generally treated as a controllable but not curable disease, and it usually relapses. Modern treatment can give long remissions, and many patients live for many years.

Does everyone need a stem cell transplant?

No. Transplant is usually offered to fitter patients, often up to about 65 to 70, after initial drug therapy. Older or less fit patients often receive drug combinations alone.

What is smouldering myeloma?

It is an earlier stage with abnormal plasma cells but no organ damage. Many patients are observed with regular tests, while higher-risk patients may be offered treatment.

How are bones protected?

Bone-strengthening drugs such as bisphosphonates or denosumab, radiotherapy for painful lesions, and sometimes surgical stabilisation help reduce fractures and pain. A dental check is advised first.

Clinical context

Working up multiple myeloma properly

A condition like multiple myeloma is rarely well-served by jumping straight to treatment shopping. The sequence below is what a oncology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.

Diagnostic workup, in sequence

  1. First-line clinical assessment

    History, physical exam, and risk-factor review by a senior generalist or oncology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.

  2. Standard imaging + labs

    Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.

  3. Specialist diagnostic workup

    Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.

  4. Multidisciplinary review (where indicated)

    Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.

When to escalate urgently

  • Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
  • Loss of consciousness, severe persistent vomiting, or any focal neurological event.
  • Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
  • If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.

Before you book international travel

  • Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
  • Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
  • Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
  • Plan for longer recovery + post-discharge therapy continuation before you fly — the surgery itself is rarely the bottleneck.
  • Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
Jinsi ukurasa huu ulivyoandaliwa

Mbinu na viwango vya uhariri

This multiple myeloma overview is written by the editorial team from published Oncology sources and lists 4 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.

  1. Taarifa za hospitali. Maelezo ya hospitali yanakusanywa kutoka vyanzo vya umma na tovuti za hospitali. Uidhinishaji (JCI, NABH na mengine) huonyeshwa pale tulipo na rekodi. Daima omba hospitali cheti chake cha sasa.
  2. Sifa za madaktari. Sifa, utaalamu na wasifu hutoka wasifu wa daktari hospitalini. Leseni hukaguliwa kwenye rejista ya baraza la kitaifa la madaktari tu pale wasifu unapoonyesha alama ya "Leseni imehakikiwa" yenye tarehe.
  3. Bei. Viwango vya bei ni vya kukadiria, vimekusanywa kutoka orodha za bei na vifurushi vya hospitali na huonyeshwa na tarehe ya mwisho ya kusasishwa. Unacholipa ni kile kilichoandikwa kwenye nukuu ya hospitali.
  4. Maandishi ya kitabibu. Imeandikwa na timu ya wahariri ya Medcasts kutoka vyanzo vya kliniki vilivyochapishwa. Isipokuwa ukurasa umetaja mhakiki kwa jina, haujakaguliwa na daktari.
  5. Uhuru. Hospitali haziwezi kulipa ili kubadilisha nafasi yao kwenye kurasa zetu.
Vyanzo vya taarifa za ukurasa huu
Peer-reviewed clinical guidelines (NCCN, ESMO, ESC, AHA, NICE — by indication)WHO ICD-11 condition classificationNational medical society treatment protocolsJCI accreditation registry

Hatua inayofuata · Multiple Myeloma

Free second opinion on your Multiple case.

Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.